The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model
The objective of this study was to investigate the in vivo activity of the lantibiotic lacticin 3147 against the luminescent Staphylococcus aureus strain Xen 29 using a murine model. Female BALB/c mice (7 weeks old, 17 g) were divided into groups (n=5) and infected with the Xen 29 strain via the int...
Saved in:
| Main Authors: | Clare Piper, Pat G. Casey, Colin Hill, Paul D. Cotter, R. Paul Ross |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | International Journal of Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2012/806230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro effects of purified lacticin from whey isolated Lactococcus lactis culture on Staphylococcus aureus and MCF-7 breast cancer cells
by: Mahtab Hosseinzadeh, et al.
Published: (2025-06-01) -
Metastatic Spreading of Community Acquired Staphylococcus aureus Bacteraemia
by: Giovanna Fabio, et al.
Published: (2011-01-01) -
Candidate genes on murine chromosome 8 are associated with susceptibility to Staphylococcus aureus infection in mice and are involved with Staphylococcus aureus septicemia in humans.
by: Qin Yan, et al.
Published: (2017-01-01) -
OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.
by: Johan A Kers, et al.
Published: (2018-01-01) -
Haematogenous Spread of Staphylococcus aureus from an Iliacus Abscess to an ACL Reconstructed Knee
by: Vivek Eranki, et al.
Published: (2013-01-01)